Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...

Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...

There is common ground. Most adults favor: Preventing chronic diseases (Republicans 86%, Democrats 91%) Protecting against ...

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies ...

Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

If the law is struck down or any ambiguity left surrounding its validity, coverage of and access to preventive care like PrEP ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

With a May 24 deadline looming, Kennedy's MAHA commission has held just one full meeting on its goal of reducing childhood ...

Many Medicare quality measures are only loosely related to actual patient outcomes. It’s time to deregulate the system, ...

For the second consecutive year, the pharma industry saw its reputation dip among patient advocacy groups, largely due to ...

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...